|
|
|
 |
| Location: Home -
Products - Active Pharma Ingredients(API) - Anti-Cancer(Oncology) API
|
Lenalidomide(CC-5013)
| Catalogue No. : |
C13805 |
| Product Name: |
Lenalidomide(CC-5013) |
| Synonym: |
Revlimid |
| Chemical Name: |
3-(7-Amino-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione |
| CAS No. : |
191732-72-6 |
| Structure : |
|
| Molecular Formula: |
C13H13N3O3 |
| Molecular Weight: |
259.26 |
| Appearance: |
Off-white to pale yellow powder |
| Purity: |
>99% |
| Usage: |
TNF-alpha Inhibitor;Lenalidomide (CC-5013, Revlimid), analogue of thalidomide, a new drug in a group known as ImiDs, with broad cytokine modulatory activity. |
|
| Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. As it is impossible for us to be informed about the patent situation in all countries, the liability for patent infringement is exclusively to be understood as buyer's risk. |
|
|
